Moderna Inc. | COVID19 vaccine technology transfer at Moderna Inc.
How other organisations have declared their voting intentions
Organisation name | Declared voting intentions | Rationale |
---|---|---|
Anima Sgr | For | As the company has faced recent criticism for its role in global COVID-19 vaccine inequity and additional information would allow shareholders to understand how the company is managing related risks. While it is noted that the demand for COVID-19 vaccines in low- and middle- income countries has significantly decreased from last year, and that Covax is working to cancel many of its existing orders of vaccines, support for this proposal is warranted given the global support for the WTO proposal waiving IP rights and criticism the company has faced for its role in inequitable vaccine distribution. |
Rothschild & co Asset Management | For | |
Kutxabank Gestion SGIIC SAU. | Against |
DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.
Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.
Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.